Pennsylvania SB866 amends the Controlled Substance, Drug, Device and Cosmetic Act to classify medetomidine as a Schedule III controlled substance and.
Pennsylvania SB866 amends the Controlled Substance, Drug, Device and Cosmetic Act to classify medetomidine as a Schedule III controlled substance. This bill also requires veterinarians to comply with specific storage and protection provisions for medetomidine and xylazine. The changes aim to regulate the use and distribution of medetomidine while ensuring its secure storage by authorized practitioners.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.